Acinetobacter baumannii international clone 2 co-producing OXA-23, NDM-1, and ArmA emerging in South America

Antimicrob Agents Chemother. 2024 May 2;68(5):e0029824. doi: 10.1128/aac.00298-24. Epub 2024 Apr 1.
No abstract available

Keywords: International clone II; Latin America; carbapenemase co-production; critical-priority pathogen; genomic surveillance; methyltransferase.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter Infections* / drug therapy
  • Acinetobacter Infections* / epidemiology
  • Acinetobacter Infections* / microbiology
  • Acinetobacter baumannii* / drug effects
  • Acinetobacter baumannii* / enzymology
  • Acinetobacter baumannii* / genetics
  • Anti-Bacterial Agents* / pharmacology
  • Humans
  • Microbial Sensitivity Tests*
  • South America / epidemiology
  • beta-Lactamases* / genetics

Substances

  • beta-Lactamases
  • beta-lactamase NDM-1
  • Anti-Bacterial Agents
  • beta-lactamase OXA-23